Real-world drug survival of ixekizumab for psoriasis

被引：9
|
作者：
Lee, Erica B. [1 ]
Pithadia, Deeti J. [2 ]
Reynolds, Kelly A. [3 ]
Reddy, Shivani P. [4 ]
Egeberg, Alexander [5 ]
Wu, Jashin J. [6 ]
机构：
[1] Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96822 USA
[2] Augusta Univ, Med Coll Georgia, Augusta, GA USA
[3] Univ Cincinnati, Coll Med, Cincinnati, OH USA
[4] Kaiser Permanente Los Angeles Med Ctr, Dept Dermatol, Los Angeles, CA USA
[5] Univ Copenhagen, Herlev & Gentofte Hosp, Dept Dermatol & Allergy, Hellerup, Denmark
[6] Dermatol Res & Educ Fdn, Irvine, CA USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2019年 / 81卷 / 01期
关键词：
PLAQUE PSORIASIS; NONRESPONDERS; EFFICACY; SAFETY; TRIALS;
D O I：
10.1016/j.jaad.2019.01.034
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：270 / 272
页数：4
相关论文
共 50 条
  • [31] Treatment switching among psoriasis patients treated with ixekizumab, secukinumab, and adalimumab in real-world settings
    Blauvelt, A.
    Shi, N.
    Burge, R.
    Malatestinic, W. N.
    Lew, C. R.
    Zimmerman, N. M.
    Amato, D.
    Zhu, B.
    Murage, M. J.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 : 24 - 24
  • [32] Real-world drug survival and reasons for treatment discontinuation of biologics and apremilast in patients with psoriasis in an academic center
    Zeb, Lawangeen
    Mhaskar, Rahul
    Lewis, Suzanna
    Patel, Nishit S.
    Sadhwani, Divya
    Patel, Nupur
    Ekhlassi, Erfon
    Lu, Yuanyuan
    Seminario-Vidal, Lucia
    DERMATOLOGIC THERAPY, 2021, 34 (02)
  • [33] Guselkumab, tildrakizumab, and risankizumab in a real-world setting: drug survival and effectiveness in the treatment of psoriasis and psoriatic arthritis
    Elgaard, Cathrine Dawn Buttner
    Iversen, Lars
    Hjuler, Kasper Fjellhaugen
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
  • [34] Drug survival of guselkumab for psoriasis in a real-world setting: a single-center retrospective chart review
    Lee, Erica B.
    Reynolds, Kelly A.
    Pithadia, Deeti J.
    Egeberg, Alexander
    Wu, Jashin J.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2020, 31 (04) : 342 - 343
  • [35] Educational service correlates with greater improvement and adherence in psoriasis patients responding to ixekizumab in a real-world setting
    Hu, K.
    Kuang, Y.
    Zhang, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S106 - S106
  • [36] Ixekizumab for the treatment of the patients with moderate to severe plaque psoriasis: Clinical data from a real-world experience
    Gonulal, Melis
    Altunay, Ilknur Kivanc
    Dogan, Sinan
    Turkmen, Meltem
    Balci, Didem Didar
    Ozturkcan, Serap
    DERMATOLOGIC THERAPY, 2022, 35 (12)
  • [37] Initial results of ixekizumab efficacy and safety in real-world plaque psoriasis patients: a multicentre retrospective study
    Deza, G.
    Notario, J.
    Lopez-Ferrer, A.
    Vilarrasa, E.
    Ferran, M.
    del Alcazar, E.
    Carrascosa, J. M.
    Corral, M.
    Salleras, M.
    Ribera, M.
    Puig, L.
    Pujol, R. M.
    Vidal, D.
    Gallardo, F.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (03) : 553 - 559
  • [38] REAL-WORLD PATIENT SATISFACTION AND QUALITY OF LIFE AMONG IXEKIZUMAB TREATED PATIENTS WITH AND WITHOUT NAIL PSORIASIS
    Gottlieb, Alice B.
    Lockshin, Benjamin
    Burge, Russel
    Malatestinic, William N.
    Zhao, Yunyang
    Feely, Meghan
    Merola, Joseph F.
    Gallardo, William Romero
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [39] Real-world evidence for ixekizumab in the treatment of psoriasis and psoriatic arthritis: literature review 2016-2021
    Reich, Adam
    Reed, Catherine
    Schuster, Christopher
    Robert, Camille
    Treuer, Tamas
    Lubrano, Ennio
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
  • [40] Efficacy, safety, and drug survival of patients with psoriasis treated with IL-17 inhibitors - brodalumab, ixekizumab, and secukinumab: real-world data from the Czech Republic BIOREP registry
    Kojanova, Martina
    Hugo, Jan
    Velackova, Barbora
    Cetkovska, Petra
    Fialova, Jorga
    Dolezal, Tomas
    Tichy, Martin
    Gkalpakiotis, Spyridon
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (06) : 2827 - 2837
12345